NCT06568172 2026-04-16
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
7 trialsNCT07144384 2026-02-13
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03567889 2025-12-17
NeoDREAM
Philogen S.p.A.
Phase 3 Recruiting
NCT07094685 2025-11-25
SENIOR-HN
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT06363591 2025-03-05
WoW
Vastra Gotaland Region
Phase NA Recruiting
NCT05794035 2023-11-30
IMPACTE-01
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT04493723 2020-07-30
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
Recruiting